The chemical industry is at a turning point, and Copernic Catalysts is building the technology to lead it—next-generation catalysts that reduce costs, lower emissions, and unlock step-change efficiency. Over the past year, our partnership with Schrödinger has led to significant breakthroughs in catalyst design, particularly in ammonia synthesis. With clear momentum and a strong technical foundation, we’re now scaling toward full commercial deployment.
At Schrödinger, our mission is clear: to improve human health and quality of life by transforming the way therapeutics and materials are discovered. That mission guides everything we do — including how we think about the efficiency of our technology. Computation is the engine that drives our company. Our industry-leading computational platform is licensed by
Over the course of my career, I’ve had the privilege of exploring a wide variety of scientific fields, from protein crystallography to drug discovery. My journey has led me through several exciting milestones, each building on the last, exploring the many ways science is evolving in the fight against disease. I earned my Ph.D. in
We are witnessing a shift toward a computational “predict-first” approach to drug discovery and materials science research, driven, in part, by Schrödinger's game-changing force field developments over the last 20 years.
Sign up to receive quarterly updates with the latest from Extrapolations.
